New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 27, 2014
12:35 EDTCAT, CRARY, GERN, GAME, CRZBY, XRX, MRK, DB, RHIOn The Fly: Midday Wrap
Stocks on Wall Street were lower at midday as a decline in new home sales last month more than offset any positive momentum built in the early hours by Caterpillar's (CAT) better than expected earning report. Stocks began the week in positive territory, briefly bouncing back from last week’s sell-off, but the market resumed its downward trend by the time the larger than expected drop in new home sales was reported near 10 am ET. As the lunch hour approached, the averages were all in the red and stood near session lows. ECONOMIC EVENTS: In the U.S., new home sales dropped 7% to a 414K rate in December from a downwardly revised 445K rate in November, missing expectations. However, the report may have been somewhat discounted as largely due to the extreme weather seen in many markets during the month. In Europe, the Ifo institute’s German business confidence measure beat economists’ forecasts and rose to its highest level in more than two years with a 110.6 reading in January. Also, the Organization for Economic Cooperation and Development reportedly estimated that European banks have a combined capital shortfall of about 84 billion euros, with Credit Agricole (CRARY), Deutsche Bank (DB) and Commerzbank (CRZBY) listed among the banks having significant gaps. COMPANY NEWS: Dow component Caterpillar advanced about 4% after its quarterly earnings easily beat the consensus expectation of analysts. The company also gave a forecast for revenue in the new fiscal year that surpassed expectations and approved a program to repurchase up to $10B of its shares. MAJOR MOVERS: Among the notable gainers was Chinese online game maker Shanda Games (GAME), which gained 13% after its controlling shareholder proposed to acquire the company in a "going private" transaction for $6.90 per American depositary share. Also higher was Robert Half (RHI), which rose 3% following an upgrade to Buy from Neutral at research firm Northcoast, which cited the valuation of its shares and expectations for top-line trends to accelerate due to easier comparisons and improving end markets. Also higher following an upgrade were shares of Merck (MRK), which gained nearly 3% after Morgan Stanley upgraded the stock two notches to Overweight from Underweight. Among the noteworthy losers was Geron (GERN), which fell 19% after disclosing that an investigator-sponsored clinical trial to evaluate imetelstat in patients with myelofibrosis and other myeloid malignancies has been closed to new patient enrollment and that the company believes approximately 20 patients have discontinued from the study since its inception. Also lower were shares of Xerox (XRX), which were downgraded to Market Perform from Outperform at BMO Capital and slid almost 5% near noon. INDEXES: Near midday, the Dow was down 76.11, or 0.48%, to 15,803.00, the Nasdaq was down 69.13, or 1.67%, to 4,059.04, and the S&P 500 was down 15.10, or 0.84%, to 1,775.19.
News For CAT;MRK;GAME;RHI;XRX;GERN;DB;CRZBY;CRARY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 1, 2015
08:22 EDTDBDeutsche Bank co-CEO Cryan says will update on strategy by end of October
In a message from John Cryan, co-CEO of Deutsche Bank, to employees posted on the bank's website, Cryan stated in part: "In my two years on the Supervisory Board, I have come to recognise that we possess many deep client relationships, skilled and committed employees, a strong brand, cultural diversity, and clear leadership in our home market with strength in many others. At the same time, you will know that our bank faces several tough challenges today. I feel it is only right to be direct and honest with you about these matters if we are to solve them. First, our reputation has been damaged by instances of serious misconduct...Second, our current financial performance does not reflect our tremendous potential...Third, we are too diversified and too complex for our own good...Fourth, we must re-engineer our internal processes...One fundamental certainty that we now possess is agreement on the six broad decisions taken as part of Strategy 2020. Those decisions were taken by the Management Board and unanimously supported by the Supervisory Board. We remain committed to them. As a new Co-CEO marking my first day in the role, I believe it right to take the summer and early autumn to decide how to best execute those decisions. We will therefore update the market with further details by the end of October."
07:52 EDTCRZBYCommerzbank sells portfolios of CRE loans totaling EUR2.9B to JPMorgan, Oaktree
Subscribe for More Information
07:14 EDTDBFormer Deutsche Bank CEO in talks with Softbank for executive role, NY Post says
Subscribe for More Information
06:56 EDTDBDeutsche Bank CEO warns staff of 'tough reforms', Reuters says
Subscribe for More Information
June 29, 2015
08:39 EDTMRKMerck says Phase 3 Emend data shows it provides 'greater protection' from nausea
Merck announced results from a Phase 3 study investigating the safety and efficacy of single-dose Emend for Injection, Merck’s substance P/neurokinin receptor antagonist, in combination with other anti-vomiting medicines, for the prevention of chemotherapy-induced nausea and vomiting, or CINV, in adult cancer patients receiving moderately emetogenic chemotherapy, or MEC. In the study, the first to evaluate an intravenous NK-1 receptor antagonist for the prevention of CINV associated with MEC, the single-dose Emend for Injection regimen provided greater protection from nausea and vomiting following administration of chemotherapy versus an active control of placebo with other anti-vomiting medicines. These data were presented in an oral session at the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology Annual Meeting on “Supportive Care in Cancer” in Copenhagen.
June 28, 2015
17:05 EDTDBBank regulator probes 'Isdafix' benchmark manipulation, FT says
Subscribe for More Information
June 26, 2015
14:46 EDTDBBaFin concludes Deutsche Bank acted 'negligently' over Libor rigging, FT reports
Subscribe for More Information
07:55 EDTDBHSBC hires Lilia Karboub to trade derivatives indexes in London, Bloomberg says
Subscribe for More Information
June 25, 2015
07:37 EDTCATExecutives' Club of Chicago to hold a discussion
Subscribe for More Information
June 24, 2015
09:07 EDTMRKCAR-T cancer drug researchers seen as M&A targets, Bloomberg says
Juno Therapeutics (JUNO), Kite Pharma (KITE) and Bluebird Bio (BLUE) are trading well above their IPO levels as takeovers predictions have spurred interest and share increases for the developers of CAR-T gene therapies, said Bloomberg's "Real M&A" column, quoting Dimo Dimov, a professor at the University of Bath’s School of Management, as having said that companies such as Pfizer (PFE), Merck (MRK), Roche (RHHBY) and AstraZeneca (AZN) are "closely watching" the firms. Cellectis (CLLS), which is working with Pfizer on its own approach to CAR-T therapy, has said it wants to bring its therapy to market and doesn’t anticipate a sale, the report noted. Reference Link
07:19 EDTDBJPMorgan names Nachimowski head of chemicals dealmaking in EMEA, Bloomberg says
Subscribe for More Information
June 22, 2015
17:46 EDTCATCaterpillar to lay off 50 more workers in East Peoria, Reuters says
Subscribe for More Information
07:49 EDTXRXXerox error-rate reduction not reflected in Street estimates, says Susquehanna
Subscribe for More Information
June 21, 2015
13:14 EDTMRKMerck shares could return 25%, Barron's says
Subscribe for More Information
June 19, 2015
10:00 EDTDBOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Aerie Pharmaceuticals (AERI) upgraded to Buy from Hold at Canaccord... Amedisys (AMED) upgraded to Buy from Hold at Jefferies... Consolidated Edison (ED) upgraded to Hold from Sell at Evercore ISI... Delta Air Lines (DAL) upgraded to Outperform from Peer Perform at Wolfe Research... Deutsche Bank (DB) upgraded to Neutral from Underperform at Exane BNP Paribas... EP Energy (EPE) upgraded on better than expected well economics at SunTrust... Encana (ECA) upgraded to Outperform from Market Perform at BMO Capital... Energy Transfer Partners (ETP) upgraded to Buy at BofA/Merrill... Erickson (EAC) upgraded to Outperform from In-Line at Imperial Capital... Fiserv (FISV) upgraded on growth opportunities, margin outlook at Oppenheimer... IPC Healthcare (IPCM) upgraded to Buy from Hold at Jefferies... Mack-Cali Realty (CLI) upgraded on valuation at Stifel... Micron (MU) upgraded to Buy on sustainable margins and capex at Topeka... NuStar Energy (NS) upgraded to Buy from Neutral at BofA/Merrill... NuStar GP Holdings (NSH) upgraded to Buy from Neutral at BofA/Merrill... Ramco-Gershenson (RPT) upgraded to Outperform from Neutral at Baird... Retail Opportunity (ROIC) upgraded to Outperform from Market Perform at Raymond James... Royal Dutch Shell (RDS.A) upgraded to Outperform from Sector Perform at RBC Capital... Smith & Wesson (SWHC) upgraded to Outperform from Sector Perform at RBC Capital... Sovran Self Storage (SSS) upgraded to Buy from Hold at Cantor... Springleaf (LEAF) upgraded to Outperform from Neutral at Macquarie.
07:02 EDTDBCanadian Solar receives $58M construction loan from Deutsche Bank
Subscribe for More Information
05:32 EDTDBDeutsche Bank upgraded to Neutral from Underperform at Exane BNP Paribas
Subscribe for More Information
June 18, 2015
11:31 EDTCATCaterpillar trends appear negative for Cummins, says Wells Fargo
Subscribe for More Information
09:15 EDTCATCaterpillar reports retail machines sales down 12% in three months end May
Caterpillar reported in a regulatory filing that its total retail machines sales were down 12% on a three month rolling basis in May. For reference, retail sales of machines were down 11% in the period ending in April and were down 12% in the period ending in March. The company reported world Resources Industries sales down 8% in the May period, which was better than the 9% drop in the April end period. Construction Industries world sales were down 14%, worse than the 12% drop in the April period. Total Energy & Transportation Retail Sales were down 6% in the May end period, which was better than the 8% decline seen in the April period.
08:59 EDTCATCaterpillar and Modustri to collaborate on equipment monitoring technology
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use